Immunohistochemical expression of single antigens in 157 patients
| Antigen . | No. of assessable samples . | No. of positive samples (%) . |
|---|---|---|
| CD10* | 157 | 41 (26%) |
| BCL6* | 146 | 94 (64%) |
| GCET1* | 146 | 67 (46%) |
| HGAL | 139 | 61 (44%) |
| IRF8 | 147 | 42 (29%) |
| LMO2* | 143 | 60 (42%) |
| Jaw1 | 149 | 126 (85%) |
| MUM1/IRF4* | 148 | 41 (28%) |
| FOXP1* | 143 | 112 (78%) |
| BLIMP1 | 147 | 66 (45%) |
| XBP1 | 104 | 28 (27%) |
| BCL2* | 152 | 76 (50%) |
| Antigen . | No. of assessable samples . | No. of positive samples (%) . |
|---|---|---|
| CD10* | 157 | 41 (26%) |
| BCL6* | 146 | 94 (64%) |
| GCET1* | 146 | 67 (46%) |
| HGAL | 139 | 61 (44%) |
| IRF8 | 147 | 42 (29%) |
| LMO2* | 143 | 60 (42%) |
| Jaw1 | 149 | 126 (85%) |
| MUM1/IRF4* | 148 | 41 (28%) |
| FOXP1* | 143 | 112 (78%) |
| BLIMP1 | 147 | 66 (45%) |
| XBP1 | 104 | 28 (27%) |
| BCL2* | 152 | 76 (50%) |
Antigens used to build up the algorithms.